BIO-TECHNE CORP COMMON (TECH) Covered Calls

Techne Corporation and subsidiaries are engaged in the development, manufacture and sale of biotechnology products and hematology calibrators and controls.

You can sell covered calls on BIO-TECHNE CORP COMMON to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for TECH (prices last updated Fri 4:16 PM ET):

BIO-TECHNE CORP COMMON (TECH) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
177.50 -5.75 177.50 196.03 361K 55 6.9B
Covered Calls For BIO-TECHNE CORP COMMON (TECH)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Nov 16 175 5.30 190.73 -8.2% -103.2%
Jan 18 175 9.00 187.03 -6.4% -25.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Bio-Techne Corp. engages in the development, manufacture, and sale of biotechnology products and clinical diagnostic controls. It operates through three segments include: Biotechnology, Clinical Controls and Protein Platforms. The Biotechnology segment is a suppliers of specialized proteins, such as cytokines, growth factors, immunoassays, antibodies and related reagents, to the biotechnology research community. The Clinical Controls segment develops and manufactures controls and calibrators for instruments in the global clinical market. The Protein Platforms segment develops, manufactures and sells tools to make protein analysis simpler, more quantitative and reproduceable. The company was founded on July 17, 1981 and is headquartered in Minneapolis, MN.